Download Unicorn Signals App

By EquityPandit

EquityPandit

EquityPandit
MARKETS

SJVN Shares Surged 5% on Arm Bagging 200 MW Solar Project

The firm’s market capitalisation stands around Rs 52,678 crore.

Shares of SJVN shot up by almost 5% on 18 March after the company’s subsidiary announced securing a 200-megawatt solar power project from Gujarat Urja Vikas Nigam Limited (GUVNL).

In its regulatory filing, the company said that its subsidiary SJVN Green Energy Limited had received a Letter of Intent (LoI) from Gujarat Urja Vikas Nigam Limited for a 200-megawatt solar power project in the GUVNL Phase–XXIII.

According to Geeta Kapur, Chairman & Managing Director of SJVN, the estimated cost of construction and development of this project is around Rs 1,100 crore and has to be developed at Gujarat State Electricity Corporation Limited, Solar Park at Khavda.

The filing added, “ The Power Purchase Agreement shall be executed with GUVNL after adoption of tariff by GERC. The project shall be commissioned in a period of 18 months from the date of signing of PPA.”

After commissioning, the project is expected to generate 508.4 million units during the first year and the project’s cumulative energy generation over 11,698.16 million units over a period of 25 years.

The company is significantly moving towards its Shared Vision of 25,000 megawatts by 2030 and 50,000 megawatts by 2040.

At 3:30 pm, the shares of SJVN shed all its early gains and closed 1.00% lower at Rs 123.35 on NSE.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
MARKETS

Stocks in Focus: RITES, Wipro, Container Corporation of India, and Others

Ali Waghbakriwala

The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.65% higher by 126 points at 24,529, indicating that the domestic benchmark indices are likely to make a positive start on Friday.

On Thursday, 24 April, Domestic benchmark indices S&P BSE Sensex slumped by 315.06 points or 0.39% and settled at 79,801.43 while the Nifty50 traded 0.34% lower by 82.25 points, settling at 24,246.70.

Here are some stocks that are likely to remain in focus on 25 April.

Quarterly Results Today: Reliance Industries, Maruti Suzuki India, L&T Finance, Cholamandalam Investment and Finance, RBL Bank, Tata Technologies, DCB Bank, Force Motors, Dr Lal PathLabs, Lloyds Metals and Energy, Hindustan Zinc, Chennai Petroleum Corporation, Bank of Maharashtra, Mahindra Lifespace Developers, Poonawalla Fincorp, Rossari Biotech, Shriram Finance, Motilal Oswal Financial Services, Oracle Financial Services Software, Tejas Networks, Zensar Technologies are some of the prominent companies set to announce their quarterly earnings for January-March. 

RITES: The company announced securing an order worth Rs 28 crore from Mahanadi Coalfields Ltd for designing and managing a railway project linked to Phase-II SILO at MCL’s Lakhanpur area.

Wipro: The company has announced the launching of the GitHub Center for Excellence in Bengaluru, which will help developers and clients build AI-powered solutions faster. 

Container Corporation of India: The company has announced that it is inking a Memorandum of Understanding (MoU) with Gail India to develop LNG infrastructure at various company terminals to provide an uninterrupted supply of LNG fuel for its road transportation requirements.

Bharat Heavy Electricals: The company has announced a fire incident on a garbage heap at its unit in Bhopal. The company stated that the fire was contained within the plantation area and there was no damage to any machinery, plant, or property. 

PB Fintech: The company announced its first investment in its subsidiary, PB Healthcare Services, for a total consideration of Rs 539 crore. The Board of Directors of the company has approved a total investment of Rs 696 crore in its subsidiary via the subscription or purchase of equity shares during the fiscal year 2026.

Tech Mahindra: In its quarterly earnings for January-March, the company reported a 76.5% year-on-year increase to Rs 1,167 crore for the quarter under review due to the expansion of margins and the effective tax rate coming down due to -one-off benefit. 

Power Grid Corporation of India: The company’s subsidiary, POWERGRID Energy Services announced the commercial operation of an 85 megawatts (MW) solar PV power plant in Ujjain, Madhya Pradesh.

Unlock profitable opportunities every day! Unicorn Signals provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Unicorn Signals and start winning now!

MARKETS

Stocks Under F&O Ban: 

Ali Waghbakriwala

Under the futures and options (F&O) segment, no stocks were banned from trade on Friday, 25 April, by the National Stock Exchange (NSE). 

Derivative contracts of these stocks were banned as the open market interest for these securities has crossed 95% of the market-wide position limit (MWPL) set by the exchanges. The MWPL is the maximum number of contracts that can be opened at any particular time.

The ban will be lifted once the position falls below 80%. Traders will get penalised for buying or selling these securities. They will be available for trading in the cash market. 

The open interest for F&O contracts of RBL Bank declined below the 80% limit. Hence, it was removed from the list on Friday

The National Stock Exchange updates the list of securities on the F&O ban list daily. This list serves as a guide for traders and investors in the market. Traders who trade in indices do not encounter a situation of security ban.

Tired of missing hot stocks? Unicorn Signals provides powerful tools like stock scans and more help you make informed trading decisions. Download now and take control of your portfolio!

MARKETS

Lupin Secures USFDA Approval for Tolvaptan Tablets; Shares Gain 

Ali Waghbakriwala

Shares of Lupin Ltd were trading in the green and 2% higher on Thursday, 24 April, after the company announced that USFDA (US Food and Drug Administration) had approved its Abbreviated New Drug Application (ANDA) for Tolvaptan tablets, which are intended to delay the deterioration of kidney function.

In an exchange filing, the company stated that it was the first to file for the product, providing it with 180 days of generic exclusivity. The medication is currently being produced at Lupin’s Nagpur facility and will be available shortly.

Tolvaptan delays the decline of kidney function in people suffering from rapidly progressive autosomal dominant polycystic kidney disease (ADPKD). According to Lupin’s exchange report, tablet sales in the United States will be over $1.47 billion by 2024.

“We are very pleased to have obtained approval for generic Tolvaptan from the USFDA. This marks a significant entry into the nephrology segment and demonstrates our commitment to addressing the unmet needs of patients globally,” said Lupin CEO Vinita Gupta.

Otsuka Pharmaceutical developed Tolvaptan tablets, a bioequivalent of Jynarque, to treat autosomal dominant polycystic kidney disease (ADPKD), a chronic condition with few therapies.

At 2:39 pm, the shares of Lupin Ltd were trading 0.69% higher at Rs 2,104 on NSE. 

Ask the analyst & get instant answer about Lupin Ltd.

Unlock profitable opportunities every day! Unicorn Signals provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Unicorn Signals and start winning now!

MARKETS

Persistent Systems Shares Rally 4% on Strong Q4 Earnings 

Ali Waghbakriwala

Shares of Persistent Systems Ltd rallied 4% on 24 April after the company announced its quarterly earnings for the fourth quarter of the fiscal year 2025.

Persistent Systems reported a total net profit of Rs 395.76 crore for the period under review, reflecting a 25.5% year-on-year (YoY) rise over the net profit of Rs 315.32 crore achieved in Q4 FY24. In Q4 FY25, the company’s operating revenue rose by more than 25% year on year to Rs 3,242 crore.

For the fiscal year ending 31 March 2025, the IT company announced a final dividend of Rs 15 per equity share in addition to its Q4 results. According to an exchange filing, the record date for determining whether stockholders are eligible to receive the payout will be made public later. The dividend given this year now stands at Rs 35, which is noteworthy. According to the firm, it planned to commemorate its 35th anniversary.

Persistent CEO and Executive Director Sandeep Kalra said, “We are proud to have delivered our 20th sequential quarter of revenue growth, with an EBIT margin of 15.6%…Despite the uncertain macroeconomic environment, our consistent performance reflects the trust of our clients, enduring strength of our capabilities, and operational discipline.”

You Might Be Interested In

Sandeep added, “As we look ahead, we are optimistic about sustaining progress to reach $2 billion in annual revenue by FY27. Our strategic pivot to AI-led platform-driven services will drive this growth, fueled by continued rigor and innovation. We are well-positioned to continue delivering consistent and differentiated long-term value for all our stakeholders.”

For the fourth quarter of fiscal year 25, the firm reported a Total Contract Value (TCV) of $517.5 million and an Annual Contract Value (ACV) of $350.2 million.

Persistent Founder, Chairman and Managing Director Anand Deshpande said, “Persistent is leading the AI-led transformation, supported by early investments, strong execution, and a clear vision to embed AI across our clients’ digital journey. Celebrating 35 years since our foundation and 15 years of being publicly listed on the National Stock Exchange of India, our unwavering commitment to innovation and client success continues to set us apart as we drive the future of technology with purpose and precision.”

At 2:02 pm, the shares of Persistent Systems were trading 0.56% higher at Rs 5,192.50 on NSE.

Stay Ahead with Persistent Systems Ltd. Ask the Analyst.

Discover the next big investment! Unicorn Signals’ IPO screener helps you identify promising initial public offerings. Download Unicorn Signals and get ahead of the curve! Sign Up Now & Find Your Next IPO Gem!

MARKETS

Thyrocare Shares Skyrocket 18% on Stellar Q4 Earnings 

Ali Waghbakriwala

Shares of Thyrocare Technologies Ltd Skyrocketed 18% on Thursday, 24 April, after the company reported strong financial results for the January-March quarter (Q4FY25).

The company’s net profit for the quarter ending March 2025 climbed by 21.9% year on year (YoY) to Rs 21.7 crore from Rs 17.8 crore in the same period last year. Profit growth was driven mostly by improved operational performance and a consistent increase in the number of diagnostic tests performed.

The revenue for the quarter increased by 21.3% YoY, from Rs 154.3 crore in Q4FY24 to Rs 187.2 crore. EBITDA, or earnings before interest, taxes, depreciation, and amortisation, increased by 70.5% to Rs 57.8 crore.

As a result, the EBITDA margin jumped to 30.9% from 22% during the same time last year. This signifies enhanced operational efficiency and cost control.

The company’s board has recommended a final dividend of Rs 21 per equity share for FY25; shareholder approval is currently pending.

Thyrocare, headquartered in Navi Mumbai, operates a vast network of diagnostic and preventative healthcare laboratories throughout India. In recent quarters, the company has concentrated on increasing its test offerings and strengthening its digital presence, which has contributed to revenue growth driven by increased testing volumes.

At 12:24 pm, the shares of Thyrocare Tech were trading 13.44% higher at Rs 872.60 on NSE. 

Wondering About Thyrocare Technologies Ltd? The Analyst Has Answers.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

@2025 - www.equitypandit.com. All Right Reserved.
Latest
IPO
Weekly
Outlook

Stock
Market
Prediction